GlassScriptPhysician profile
Lauren E Roeder
NPI 1730863069
$1,956.10
in general payments reported to CMS, 2019-2025
9 companies · $896 in 2025
The $896 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $465 · 2024: $595 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,100 · Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,100.49 |
| Food and Beverage | $855.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,100.49 | 2023-2025 | Actis, Stratafix |
| Kerecis Limited | $229.02 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $211.10 | 2024-2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $138.22 | 2024-2025 | Persona, G7, Ncb |
| Elite Orthopedics, LLC | $128.30 | 2024-2025 | |
| Depuy Synthes Sales INC. | $68.10 | 2023-2024 | Na, Teligen, Motoband |
| Axogen | $37.61 | 2025 | |
| Solventum Corporation | $23.20 | 2024 | Prevena |
| Stryker Corporation | $20.06 | 2025 | Variax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Roeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.